
Voyager Therapeutics
This company is dedicated to breaking through barriers in gene therapy and neurology.
Market cap
$190m
Enterprise value
$178m
Share price
$3.42 VYGR
Authorizing premium user...
This company is dedicated to breaking through barriers in gene therapy and neurology.